Bundesweites Belastungsmodell für Intensivstationen durch COVID-19

por Schuppert, A., Theisen, S., Fränkel, P., Weber-Carstens, S., Karagiannidis, C.
Publicado 2021

A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas

por Eroglu, Z, Tawbi, H A, Hu, J, Guan, M, Frankel, P H, Ruel, N H, Wilczynski, S, Christensen, S, Gandara, D R, Chow, W A
Publicado 2015

Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer

por Somlo, G, Simpson, J F, Frankel, P, Chow, W, Leong, L, Margolin, K, Morgan, R, Raschko, J, Shibata, S, Forman, S, Kogut, N, McNamara, M, Molina, A, Somlo, E, Doroshow, J H
Publicado 2002

Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors

por Koczywas, M, Frankel, P H, Synold, T W, Lenz, H-J, Mortimer, J E, El-Khoueiry, A B, Gandara, D R, Cristea, M C, Chung, V M, Lim, D, Reckamp, K L, Lau, D H, Doyle, L A, Ruel, C, Carroll, M I, Newman, E M
Publicado 2014